Skip to content

Research for the relationship between clinical markers and Coronary Atherosclerosis

Research for the relationship between clinical markers and Coronary Atherosclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RO-13003377
Enrollment
Unknown
Registered
2013-07-16
Start date
2013-08-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Atherosclerosis

Interventions

1:NA

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. standards of healthy control subjects: (1) healthy people,without Cardiovascular System diseases and other renal or hepatic system diseases; (2) sbjects are aged 60+/-20, who volunteer to participate in this study; (3) written informed consent was obtained from all subjects. 2. standards of coronary atherosclerosis patients: (1) August 2013 to September 2013, coronary atherosclerosis patients in nanfang hospital, who were diagnosed with coronary atherosclerosis patient according to The People's Republic of China health departmentd diagnostic criteria of Coronary Atherosclerosis; (2) subjects are aged 60+/-20, Gender Not Required; (3) drugs are forbidden 24 hours before test; (4) written informed consent was obtained from all subjects.

Exclusion criteria

Exclusion criteria: 1. Female patients who are pregnant or breastfeeding; 2. patients with disease including Hepatitis or its virus carriersbile duct occlusion, cholestasis, Hypertension, Pulmonary Heart Disease, caner, Rheumatic Heart disease and other severe diseases; 3. Does not meet the inclusion criteria and case report forms irregularities.

Design outcomes

Primary

MeasureTime frame
HDL-C;VLDL-C;LDL-C;LP(a);TG;CHOL;CRP;apoAI;apoE;apoB;MircoRNA-;MicroRNA-21;MircoRNA-122;MicroRNA-126;MCP-1;TGF-ß;PPAR;IFN-?;LXA1;IL-4;IL-4;IL-18;IL-8;IL-12;LTB4;

Countries

China

Contacts

Public ContactQian Wang
wangqian@fimmu.com+86 020-61641007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026